Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD62L vs CD45RA Depleted DLI in Haploidentical HSCT
NCT07867769Phase 2Recruiting
- Sponsor
- Hong Kong Children’s Hospital
- Start
- Oct 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Phase 2, randomised trial (2 arms), sponsored by Hong Kong Children’s Hospital. Primary endpoint: Frequency of viral infections at 100 days. Started Oct 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07867769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07867769.